Foghorn Therapeutics Inc.
FHTX
Revenue
8.15M
▲596.00k▲7.89%
3 Months ChangeAssets
204.96M
▼-21.27M▼-9.40%
3 Months ChangeLiabilities
294.62M
▼-8.28M▼-2.73%
3 Months ChangeFree Cash Flow
-24.00M
▲5.45M▲18.51%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-23
Form 8-K
ID: 0001628280-26-010377
2026-01-12
Form 8-K
ID: 0001193125-26-009885
2025-12-04
Form 8-K
ID: 0001628280-25-055215
2025-11-07
Form 8-K
ID: 0001628280-25-050683
2025-11-05
Form 10-Q
ID: 0001628280-25-049238
2025-11-05
Form 8-K
ID: 0001628280-25-049236
2025-10-30
Form 8-K
ID: 0001628280-25-047322
2025-09-02
Form 8-K
ID: 0001822462-25-000007
2025-08-05
Form 10-Q
ID: 0001628280-25-037606
2025-08-05
Form 8-K
ID: 0001628280-25-037603